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A B S T R A C T
A 71-year-old female complained of abdominal pain, weight loss and abdominal distension. Gynecologic examination
revealed a hardly movable, palpable mass in the lower abdomen, reaching the umbilicus. An abdominal ultrasound and
computed tomography (CT) scan suggested a large abdominal mass with the possible origin in the left ovary and without
significant lymph node enlargements. The patient subsequently underwent complete evacuation of tumor tissue, omen-
tectomy and total abdominal hysterectomy and bilateral salpingo-ovariectomy. Immunohistochemical examination re-
vealed strongly positive staining of tumor cells for CD117. The final pathologic diagnosis was a primary extragastro-
intestinal stromal tumor (EGIST) of the sigmoid mesocolon with omental metstasis. The differential diagnosis of the
tumor presented in the lower abdomen should consider the EGIST as well.
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Introduction
Gastrointestinal stromal tumors (GISTs) are the most
common mesenchymal tumor of the gastrointestinal (GI)
tract. GISTs express c-kit protein also known as CD117,
which is considered as a highly specific marker that dif-
ferentiates it from other mesenchymal tumors1. Neo-
plasms with histology and immunohistochemistry simi-
lar to GISTs may occur outside the GI tract, for example
in the soft tissue of the abdominal cavity (omentum and
mesentery) or in the retroperitoneum2. GIST that arises
primarily outside the GI tract is termed extragastro-
intestinal stromal tumor (EGIST). While the histoge-
nesis, prognostic parameters and outcomes of GISTs are
widely known, pathogenesis, incidence and prognosis of
EGISTs have not yet been completely defined. We report
the results of the macroscopic and microscopic examina-
tions, including immunohistochemical studies, of an EGIST
of the sigmoid mesocolon.
Case Report
A 71-year-old woman presented with abdominal pain
and pressure of 3 months duration, accompanied by ane-
mia and a weight loss of 4 kilograms. There was no fam-
ily history of malignant diseases. Physical examination
revealed a hardly movable, palpable mass in the lower
abdomen, reaching the umbilicus. The abdominal ultra-
sound discovered a solid, highly vasculated mass (25x15
cm) with numerous shunts, located in the pelvic cavity
(behind the uterus) and abdomen. The resistive index
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(RI) in the mass was 0.32 to 0.37. The laboratory values
and common tumor markers (CA125, CEA, CA19-9) were
within normal range with the exception of hemoglobin
83 g/L. The computed tomography (CT) scan suggested a
large lower abdominal mass with possible origin in the
left ovary and without significant lymph node enlarge-
ments noted. Intraoperatively, we found a large round-
-shaped mass located in the lower abdomen with multi-
ple adhesions to the sigmoid mesocolon, sigmoid colon
and uterus. The greater omentum was consumed with
multiple tumor nodules whose size varied from 0.7 mm
to 27 mm. After adhesiolysis the tumor was removed en-
tirely (Figure 1) and total abdominal hysterectomy with
bilateral salpingo-ovariectomy and total omentectomy
were performed. Exploration of the abdominal cavity dis-
played no more tumor masses in abdomen.
Pathology analysis revealed that the uterus, both
tubes and ovaries, were free of tumor cells.
Macroscopically, the tumor was lobulated, round-sha-
ped, of 29x23x12 cm in size; it had free margins, central
parts of local necrosis and hemorrhage in almost 20% of
the tissue. Microscopically, the tumor consisted of nests,
clusters and pseudoglandular cords of uniform appear-
ance, epitheloid polygonal cells with eosinophilic, vari-
ably vacuolated cytoplasm (physalipherous-like cells).
Transitions between large eosinophilic cells and spindle
ones were interspersed. The tumor cells embedded in fo-
cally myxoid stroma were separated by fibrous tissue.
The mitotic activity was 2–5 mitosis/50 high-power field
(HPF). There was no residual muscular tissue from the
gut wall in the tumor pseudocapsule. Immunohistoche-
mistry showed positive reactions of tumor cells for vi-
mentin, bcl-2 and CD99 as well as positive focal reactions
for neuron specific enolase (NSE). Reactions of tumor
cells for HBME-1, CA125, CK7, CK20, CK5/6 and CKAE1/
AE3 were negative. Primitive neuroectodermal tumor
(PNET) was first suspected and reverse transcription
polymerase chain reaction (RT-PCR) was introduced to
reach a final conclusion. RT-PCR analysis showed a nega-
tive reaction for EWS/FLI-1 for both types and negative
reactions for SYT/SSX1 and SYT/SSX2. Therefore the
initial diagnosis of PNET was rejected. Further immu-
nohistochemical analysis revealed positive reactions of
tumor cells for calponin, S-100, and diffuse strong CD117
positivity. Reactions of tumor cells for leucocyte common
antigen (LCA), chromogranin, sinaptophisin, carcinoem-
bryonic antigen (CEA), cytokeratin 19, CK18, Melan-A,
HMB45, CD34, smooth muscle actin (SMA), desmin, epi-
thelial membrane antigen (EMA) and glial fibrillary aci-
dic protein (GFAP) were negative. These findings strong-
ly supported a diagnosis EGIST. The patient recovered
well and 8 days after the surgical procedure she was dis-
charged from the hospital to home care. The 16-month
follow-up has shown no tumor recurrence to date.
Discussion
The GISTs are the most common mesenchymal tu-
mors of the GI tract with an incidence estimated at 7 to
14 per 1 million in the general population3. These tumors
usually occur in the stomach (60–70%) and small intes-
tine (20–35%), with rare occurrence in the colon and rec-
tum (5%), esophagus (<2%) and appendix3–5. Some GISTs
are unrelated to the tubular gastrointestinal tract and
they are termed EGISTs. Incidence of EGISTs is not de-
fined yet3. EGISTs are probably rarer than previously re-
ported. Most cases of EGISTs are likely to represent mural
GISTs with extensive extramural growth with eventual
loss of contact with the muscle layer of the gut6. GISTs
should be defined by virtue of any degree of association
with the muscularis propria (supported by desmin immu-
noreactivity), but not by localization of the bulk of the
tumor6,7.
EGISTs arising in the mesentery of sigmoid colon are
extremely rare. A total of 99 omental and mesenteric
EGISTs have been reported in four published series from
1999 to 20083.
EGIST have various clinical behavior, and the param-
eters used for predicting the prognosis of GIST may not
be completely suitable for EGIST evaluation. Miettinen
et al. examined seven cases of mesenteric EGISTs and
nine cases of omental EGISTs. Mesenteric EGISTs ap-
peared more aggressive (higher mitotic activity, frequent
malignant behavior)8.
Reith et al.9 noted that EGIST arising within the ab-
dominal cavity (40 cases) and the retroperitoneum (8
cases) expressed CD117 (100%), CD34 (50%), neuron-
-specific enolase (44%), smooth muscle actin (26%), des-
min (4%), and S-100 protein (4%). High cellularity, mi-
totic activity (>2 mitoses/50 HPF) and the presence of
necrosis were factors indicative of a potentially aggres-
sive clinical course for EGIST. Our patient displayed two
high-risk features (mitotic activity >2/50 HPF and pres-
ence of necrosis). Tumor size, which is commonly used in
GISTs as a prognostic factor, is not applicable to EGISTs9,10.
EGISTs appear to have enough space to grow and they
are often large size, presenting clinical symptoms only
after a long time. Since the preoperative diagnosis based
on clinical and radiological data is difficult, the patients
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usually undergo a surgical operation for the generic diag-
nosis of »abdominal mass« or suspected gynecological
tumor3,11. Our patient had nonspecific imaging features
on abdominal ultrasound and CT scan that could mimic
the ovarian tumor.
An aggressive surgical approach is the most effective
treatment12. Lymphadenectomy is not required13.
Conclusion
This case draws our attention to the importance of
considering EGISTs in the differential diagnosis of a tu-
mor mass in the lower abdomen. Especially surgeons as
well as diagnostic pathologists should be aware of this
possibility. In most cases a preoperative diagnosis is not
possible.
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PRIMARNI EKSTRAGASTROINTESTINALNI STROMALNI TUMOR MEZENTERIJA SIGMOIDNOG
DEBELOG CRIJEVA S METASTAZAMA U VELIKOM OMENTUMU: PRIKAZ SLU^AJA
S A @ E T A K
@ena u dobi od 71 godinu `alila se na bol u trbuhu, nadutost i gubitak tjelesne te`ine. Ginekolo{kim pregledom
palpirala se slabo pomi~na tumorska masa u donjem trbuhu koja je sezala do pupka. Abdominalnim ultrazvukom i
kompjutoriziranom tomografijom prikazana je velika tumorska tvorba u trbuhu koja vjerojatno potje~e od lijevog jaj-
nika. Pove}ani limfni ~vorovi nisu prikazani. Kirur{kim je zahvatom u potpunosti odstranjeno tumorsko tkivo, u~inje-
na je omentektomija i totalna abdominalana histerektomija s obostranom adneksektomijom. Imunohistokemijskim
bojanjem dokazana je jaka pozitivnost tumorskih stanica na CD117. Kona~na dijagnoza je bila primarni ekstragastro-
intestinalni stromalni tumor (EGIST) mezenterija sigmoidnog debelog crijeva s metastazama u velikom omentumu.
Diferencijalano dijagnosti~ki kod tumora donjeg abdomena uvijek treba uzeti u obzir EGIST.
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